Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Accidental dextromethorphan poisoning |
Causative agent |
False |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Some |
|
Intentional dextromethorphan poisoning |
Causative agent |
False |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Some |
|
Forgiftning med dextrometorfan, uvist med hvilken hensigt |
Causative agent |
False |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Some |
|
allergi over for dextromethorphanhydrobromid |
Causative agent |
False |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Some |
|
carbinoxaminmaleat 4 mg/5 ml + dextromethorphanhydrobromid 15 mg/5 ml + pseudoephedrinhydrochlorid 60 mg/5 ml syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Some |
|
carbinoxaminmaleat + dextromethorphanhydrobromid + pseudoephedrinhydrochlorid 2 mg/1 ml/4 mg/1 ml/25 mg/1 ml væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Some |
|
carbinoxaminmaleat 2 mg/1 ml + dextromethorphanhydrobromid 4 mg/1 ml + pseudoephedrinhydrochlorid 15 mg/1 ml væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Some |
|
brompheniraminmaleat + dextromethorphanhydrobromid + phenylpropanolaminhydrochlorid 2 mg/5 ml 10 mg/5 ml 12,5 mg/5 ml syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Some |
|
brompheniraminmaleat + dextromethorphanhydrobromid + pseudoephedrinhydrochlorid 2 mg/5 ml 10 mg/5 ml 30 mg/5 ml syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Some |
|
brompheniraminmaleat + dextromethorphanhydrobromid + pseudoephedrinhydrochlorid 4 mg/5 ml 15 mg/5 ml 60 mg/5 ml syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Some |
|
brompheniraminmaleat 2 mg + dextromethorphanhydrobromid 10 mg + phenylpropanolaminhydrochlorid 12,5 mg væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Some |
|
dextromethorphanhydrobromid 15 mg + promethazinhydrochlorid 6,25 mg væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Some |
|
brompheniraminmaleat + dextromethorphanhydrobromid + pseudoephedrinhydrochlorid 4 mg/5 ml 15 mg/5 ml 45 mg/5 ml syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Some |
|
brompheniraminmaleat 4 mg/5 ml + dextromethorphanhydrobromid 30 mg/5 ml + pseudoephedrinhydrochlorid 60 mg/5 ml syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Some |
|
carbinoxaminmaleat + dextromethorphanhydrobromid + pseudoephedrinhydrochlorid 4 mg/5 ml/12,5 mg/5 ml/60 mg/5 ml syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Some |
|
carbinoxaminmaleat + dextromethorphanhydrobromid + pseudoephedrinhydrochlorid 1 mg/1 ml/4 mg/1 ml/15 mg/1 ml dråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Some |
|
dextromethorphanhydrobromid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Some |
|
Poisoning by dextromethorphan |
Causative agent |
False |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Some |
|
brompheniraminmaleat + dextromethorphanhydrobromid + pseudoephedrinhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Some |
|
carbinoxaminmaleat + dextromethorphanhydrobromid + pseudoephedrinhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Some |
|
dextromethorphanhydrobromid 6,67 mg/5 ml syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Some |
|
dextromethorphan 7,5 mg pastil |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Some |
|
dextromethorphanhydrobromid + promethazinhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Some |
|
dextromethorphanhydrobromid 7,5 mg/5 ml eliksir til oral anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Some |
|
dextromethorphanhydrobromid 7,5 mg/5 ml syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Some |
|
brompheniraminmaleat + dextromethorphanhydrobromid + phenylpropanolaminhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Some |
|
Accidental dextromethorphan poisoning |
Causative agent |
False |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Some |
|
Intentional dextromethorphan poisoning |
Causative agent |
False |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Some |
|
allergi over for dextromethorphanhydrobromid |
Causative agent |
False |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Some |
1 |
allergi over for dextromethorphanhydrobromid |
Causative agent |
False |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Some |
2 |
Dextromethorphan hydrobromide monohydrate (substance) |
Is a |
False |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Some |
|
Dextromethorphan hydrobromide monohydrate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Some |
|
Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Some |
3 |
Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Some |
3 |
Dextromethorphan hydrobromide 3 mg/mL and promethazine hydrochloride 1.25 mg/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Some |
2 |
Dextromethorphan hydrobromide 3 mg/mL and promethazine hydrochloride 1.25 mg/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely brompheniramine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 9 milligram/1 milliliter conventional release oral solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Some |
3 |
Product containing precisely brompheniramine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 9 milligram/1 milliliter conventional release oral solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Some |
3 |
Product containing precisely dextromethorphan hydrobromide 1.5 milligram/1 milliliter conventional release oral solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely dextromethorphan hydrobromide 1.5 milligram/1 milliliter conventional release oral solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Some |
1 |
Dextromethorphan hydrobromide 1.33 mg/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Some |
1 |
Dextromethorphan hydrobromide 1.33 mg/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely dextromethorphan hydrobromide 30 milligram and guaifenesin 600 milligram/1 each prolonged-release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely dextromethorphan hydrobromide 30 milligram and guaifenesin 600 milligram/1 each prolonged-release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Some |
1 |
Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and pseudoephedrine hydrochloride 6 mg/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Some |
3 |
Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and pseudoephedrine hydrochloride 6 mg/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Some |
3 |
Dextromethorphan hydrobromide 60 mg and guaifenesin 1.2 g prolonged-release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Some |
1 |
Dextromethorphan hydrobromide 60 mg and guaifenesin 1.2 g prolonged-release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely carbinoxamine maleate 1 milligram/1 milliliter and dextromethorphan hydrobromide 4 milligram/1 milliliter and pseudoephedrine hydrochloride 15 milligram/1 milliliter conventional release oral solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Some |
3 |
Product containing precisely carbinoxamine maleate 1 milligram/1 milliliter and dextromethorphan hydrobromide 4 milligram/1 milliliter and pseudoephedrine hydrochloride 15 milligram/1 milliliter conventional release oral solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Some |
3 |
Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 2.5 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Some |
3 |
Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 2.5 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Some |
3 |
Dextromethorphan hydrobromide anhydrous |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Some |
|
Product containing precisely dextromethorphan hydrobromide 7.5 milligram and paracetamol 500 milligram and promethazine hydrochloride 10 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely dextromethorphan hydrobromide 7.5 milligram and paracetamol 500 milligram and promethazine hydrochloride 10 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely dextromethorphan hydrobromide 750 microgram/1 milliliter and paracetamol 50 milligram/1 milliliter and promethazine hydrochloride 1 milligram/1 milliliter conventional release oral solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely dextromethorphan hydrobromide 750 microgram/1 milliliter and paracetamol 50 milligram/1 milliliter and promethazine hydrochloride 1 milligram/1 milliliter conventional release oral solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely dextromethorphan hydrobromide 1.3 milligram/1 milliliter and diphenhydramine hydrochloride 2.8 milligram/1 milliliter and levomenthol 400 microgram/1 milliliter conventional release oral solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely dextromethorphan hydrobromide 1.3 milligram/1 milliliter and diphenhydramine hydrochloride 2.8 milligram/1 milliliter and levomenthol 400 microgram/1 milliliter conventional release oral solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Some |
2 |